These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11070698)

  • 1. [The 2f1-f2 DPOAE amplitudes and latencies in the groups of older people with presbyacusis and young people with normal hearing].
    Namysłowski G; Morawski K; Urbaniec P; Lisowska G
    Otolaryngol Pol; 2000; 54(4):423-9. PubMed ID: 11070698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latencies of the 2f1-f2 distortion product otoacoustic emissions measured using a phase-gradient method in young people, in the elderly and in people exposed to noise.
    Namyslowski G; Morawski K; Urbaniec P; Trybalska G; Lisowska G
    Scand Audiol Suppl; 2001; (52):121-5. PubMed ID: 11318441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. I. Intersubject variability and consequences on the DPOAE-gram.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1460-70. PubMed ID: 10738801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
    Kossowski M; Mom T; Guitton M; Poncet JL; Bonfils P; Avan P
    Audiology; 2001; 40(3):113-22. PubMed ID: 11465293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine structure of distortion product otoacoustic emissions: its dependence on age and hearing threshold and clinical implications.
    Wagner W; Plinkert PK; Vonthein R; Plontke SK
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1165-72. PubMed ID: 18301908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase delay measurements of distortion product otoacoustic emissions at 2f1-f2 and 2f2-f1 in human ears.
    Wable J; Collet L; Chéry-Croze S
    J Acoust Soc Am; 1996 Oct; 100(4 Pt 1):2228-35. PubMed ID: 8865631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender, music, and distortion product otoacoustic emission components.
    Torre P; Grace J; Hansen C; Millman P; Martin H
    Ear Hear; 2013; 34(6):e74-81. PubMed ID: 23698624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPOAE in estimation of the function of the cochlea in tinnitus patients with normal hearing.
    Sztuka A; Pospiech L; Gawron W; Dudek K
    Auris Nasus Larynx; 2010 Feb; 37(1):55-60. PubMed ID: 19560298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separating the contributions of olivocochlear and middle ear muscle reflexes in modulation of distortion product otoacoustic emission levels.
    Wolter NE; Harrison RV; James AL
    Audiol Neurootol; 2014; 19(1):41-8. PubMed ID: 24335024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions.
    Parazzini M; Hall AJ; Lutman ME; Kapadia S
    Hear Res; 2005 Jul; 205(1-2):44-52. PubMed ID: 15953514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The latencies of the 2f1-f2 DPOAE measured using phase gradient method in young adults and in workers chronically exposed to noise.
    Namysłowski G; Morawski K; Trybalska G; Urbaniec P
    Otolaryngol Pol; 2004; 58(1):131-8. PubMed ID: 15101272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distortion product otoacoustic emissions for the assessment of auditory sensitivity].
    Chida E
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Nov; 101(11):1335-47. PubMed ID: 9867000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of systematic primary-tone level variation L2-L1 on the acoustic distortion product emission 2f1-f2 in normal human ears.
    Hauser R; Probst R
    J Acoust Soc Am; 1991 Jan; 89(1):280-6. PubMed ID: 2002169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.